[
  {
    "ts": null,
    "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
    "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
    "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740009540,
      "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
      "id": 132792928,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1156718067/image_1156718067.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
      "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554"
    }
  },
  {
    "ts": null,
    "headline": "10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers",
    "summary": "Discover our top dividend-yield stocks & reader favorites for 2025! See the best performers by net gains, price upside, and yield. Click for the exclusive picks.",
    "url": "https://finnhub.io/api/news?id=28ffebdbb9b2491e4260010eacb12301c74fc6c7b69600ea32233974bfa8f519",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739988476,
      "headline": "10 Ideal 'Safer' January Dividend Buys, Out Of 40 Choices From Readers",
      "id": 132791627,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1291579521/image_1291579521.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Discover our top dividend-yield stocks & reader favorites for 2025! See the best performers by net gains, price upside, and yield. Click for the exclusive picks.",
      "url": "https://finnhub.io/api/news?id=28ffebdbb9b2491e4260010eacb12301c74fc6c7b69600ea32233974bfa8f519"
    }
  },
  {
    "ts": null,
    "headline": "Why Chipotle is turning to AI as it steps up its seasonal hiring to 20,000",
    "summary": "Why Chipotle is turning to AI as it steps up its seasonal hiring to 20,000",
    "url": "https://finnhub.io/api/news?id=29c979556b79ff62312d877accf91549807bbc58e4f92ca722f552e29d9a53f7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739979840,
      "headline": "Why Chipotle is turning to AI as it steps up its seasonal hiring to 20,000",
      "id": 132796713,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Why Chipotle is turning to AI as it steps up its seasonal hiring to 20,000",
      "url": "https://finnhub.io/api/news?id=29c979556b79ff62312d877accf91549807bbc58e4f92ca722f552e29d9a53f7"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
    "summary": "January hits new highs with $814 in dividend income, up 21% Y/Y. See how BDC investments drive growth toward $11,000 annual dividends.",
    "url": "https://finnhub.io/api/news?id=5455f567381019beddc413e7e5eb783a45482cdef95f6ee343bcfd391c577c6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739952600,
      "headline": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
      "id": 132784079,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "January hits new highs with $814 in dividend income, up 21% Y/Y. See how BDC investments drive growth toward $11,000 annual dividends.",
      "url": "https://finnhub.io/api/news?id=5455f567381019beddc413e7e5eb783a45482cdef95f6ee343bcfd391c577c6d"
    }
  },
  {
    "ts": null,
    "headline": "Why Pfizer's Stock Price Isn't Reflecting Its True Value",
    "summary": "Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for income-focused investors.",
    "url": "https://finnhub.io/api/news?id=a93b031d701698c17a77be5b35f9210315f89f49ce3bc2e7461660b1e29621da",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739949743,
      "headline": "Why Pfizer's Stock Price Isn't Reflecting Its True Value",
      "id": 132783690,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1208383718/image_1208383718.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for income-focused investors.",
      "url": "https://finnhub.io/api/news?id=a93b031d701698c17a77be5b35f9210315f89f49ce3bc2e7461660b1e29621da"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock's Upside Got Bigger",
    "summary": "Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy rating on PFE stock.",
    "url": "https://finnhub.io/api/news?id=8edabd30d007c26229640d5920aed614a745d429d76e2182bc5975bcee51ef86",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739935868,
      "headline": "Pfizer Stock's Upside Got Bigger",
      "id": 132782619,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1491484031/image_1491484031.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy rating on PFE stock.",
      "url": "https://finnhub.io/api/news?id=8edabd30d007c26229640d5920aed614a745d429d76e2182bc5975bcee51ef86"
    }
  }
]